Xeris Pharmaceuticals ( NASDAQ: XERS ) is scheduled to announce Q2 earnings results on Thursday, August 8th, before market open. The consensus EPS Estimate is -$0.09 and the consensus Revenue Estimate is $45.
81M (+20.5% Y/Y). Over the last 3 months, EPS estimates have seen 1 upward revision and 1 downward.
Revenue estimates have seen 4 upward revisions and 1 downward. More on Xeris Pharmaceuticals Xeris Biopharma Holdings, Inc. (XERS) Q1 2024 Earnings Call Transcript Xeris stock jumps 14% on Phase 2 data for injected levothyroxine Seeking Alpha’s Quant Rating on Xeris Pharmaceuticals Historical earnings data for Xeris Pharmaceuticals Financial information for Xeris Pharmaceuticals.
